LIPA CITY COLLEGES

COLLEGES OF NURSING

Case Study of
CAESAREAN SECTION
Presented by:
Claudio, Urich Matthew A.
Latade, April Lou A.
Magpantay, Mecaela Lorie F.
Morcilla, Krisha Denise A.
Rivera, Rose Angela G.
Villanueva, Chantemayne M.
 
BSN - II C – GROUP 9
WARD
 Table of Contents
 
 
 
 
I. Introduction
II. General / Specific Objectives
III. Case Description
IV. Patient’s Profile
V. Health History of the Patient
VI. Physical Assessment
VII.Review of Anatomy and Physiology
VIII.Pathophysiology
IX. Laboratory Findings
X. Nursing Care Plan
XI. Drug Study
XII.Resume and Vax Cert of Students
 INTRODUCTION
A caesarean section is a surgical procedure that involves delivering a baby through a cut in the mother's
abdominal wall and uterus. If there are serious problems that prevent the baby from being born vaginally,
the baby will need to be delivered via caesarean section. What exactly is a Cesarean section? The
surgical delivery of a baby through a cut (incision) made in the mother's abdomen and uterus is known as
a cesarean section, C-section, or Cesarean birth. It is used by health care providers when they believe it
is safer for the mother, the baby, or both. When a vaginal delivery would endanger the baby or the
mother, a caesarean section is often required. Obstructed labor, twin pregnancy, high blood pressure in
the mother, breech birth, or problems with the placenta or umbilical cord are all examples.

C-sections are generally considered safe. However, the risk of major complications during surgery is
greater than that of vaginal birth. Some of the increased risk is due to the reason for the recommendation
of cesarean delivery rather than the procedure itself. When labor and delivery are without complications,
vaginal birth is preferred over cesarean. Cesarean delivery is clearly indicated in some cases. The use of
C-sections in these situations has made delivery significantly safer for both mother and child.

You should not carry anything heavier than the baby for the first few weeks after a C-section.
Breastfeeding can begin as soon as you are awake in the recovery room after surgery. The "football
hold," in which the baby's body is under your arm and the head is near your breast, can help keep the
baby's weight off the incision.
 GENERAL/ SPECIFIC OBJECTIVES

General Objectives:
 
 To deliver the baby safely by making abdominal and uterine incisions in the mother
 To decrease mother and infant deaths and injuries
 To decrease mother and infant risk for any possible diseases
 To make patient preparation possible

Specific Objectives:
 
 To provide health education necessary for the patient's quick recovery and to avoid any possible
complications and also to create discharge planning
 CASE DESCRIPTION

Patient A is a 32-year-old, female, married, residing at

Unit 3233 Celandine, 115A- Bonifacio Ave. Brgy.
Balingasa, Quezon City and was admitted with the chief
complaint of Cesarean Section. Before her first
pregnancy she was diagnosed with PCOS (Polycystic
Ovary Syndrome) year 2017. Diagnosed with
Gestational Diabetes Mellitus and on controlled diet after
giving birth.
 PATIENT’S PROFILE
Name: Patient D

Age: 32

Birthdate: May 15,1990

Gender: Female

Address: 115-A A. Bonifacio Ave. Balingasa Quezon City, NCR Second District

Birthplace: Batangas

Civil Status: Marrie

Religion: Roman Catholic

Occupation: Pediatrician Doctor

 PATIENT’S PROFILE
Height: 152 cm

Weight: 56kg

BMI: 24.8 (Normal Category)

 
Admitting Diagnosis: G1P0 Pregnancy Urine 39 2/7 Weeks, AOG
Admission Case Type: Small/ Regular Private
Final Diagnosis: G1P1 (1001) Pregnancy Uterine, delivered Term, Cephalic, Childbirth
Failure in Descent
Operation:
LSCS I (Pfannenstiel) - LSCS - Low Segment Cesarean Section
COVID Tested Negative: November 9, 2022 / 3:09 PM
Date of Admission/Time: November 14, 2022 / 8:00 AM
Date of Discharge: November 17, 2022
 HEALTH HISTORY OF THE PATIENT

Chief Complaint
 
"Wala namang ibang masakit sa akin kundi tahi ko na lang at nahihirapan ako maglakad" as verbalized by
the patient.
 
History of patient's illness
 
Three days prior to admission, during her PNCU (Perinatal Care Unit), IE was 2 cm. Patient still had
irregular contraction. She was advised for TCB (Transcutaneous Bilirubin) after 3 days for induction of
labor.
 
 HEALTH HISTORY OF THE PATIENT

Present Medical History

 
The patient can only feel the pain on the suture, and she still has slightly edema on her one foot.
Pain Scale: 9/10
 
Past Medical History
 
Patient F has no history of asthma and no allergies, not even on drugs and food. But she was
diagnosed before for PCOS (polycystic ovarian syndrome) around 2017 and according to the patient
when she had been checked, her Doctor only prescribed a medicine to her. She was admitted to the
hospital on November 14, 2022, at 8:00am for delivering her baby. At first, she was supposed to have
NSD (Normal Spontaneous Delivery) but since she's not yet full dilated and the baby
 HEALTH HISTORY OF THE PATIENT

needs to be out of the womb, she has been through CS Delivery. The patient was also diagnosed
for GDM (Gestational Diabetes Mellitus).
 
Family History
 
The patient stated that her family has history of asthma and allergies. Her father and siblings
have asthma, allergic rhinitis, seafood allergies, food allergies and childhood asthma.
 
Personal, Social, and Lifestyle History
 
Patient F is 32 years old, female and she lived at Unit 3233 Celandine, 1151-A, Bonifacio Ave.
Brgy. Balingasa, Quezon City Philippines 1008. She is a Pediatrician Doctor. She is married to
Gamaliel Issamar De Vera. She's also strict to her diet. Her exercise was walking. She only had
one child that was newborn.
 PHYSICAL EXAMINATION
AREA/SYSTEM NORMAL FINDINGS
Abdomen    Fetal heart rate monitoring may
   
Fetal Heart Rate has an
average or normal finding
within 110 to 160 BPM
 
100% Lightening/ Effaced
Rectum & Genitalia  
  10 cm Dilated
FINDINGS INTERPRETATION
help detect changes in the
Fetal Heart Tone of the baby normal heart rate pattern during
is in the Left Lower Quadrant labor.
and has a 140 BPM  
Upon monitoring of the baby’s
FHT the baby has a normal
FHT which is 140 BPM.
IE: 2-3 cm dilated, 50% The normal effaced and
efface, ST 0, cephalic intact dilation does not meet before
Bow laboring.
 REVIEW OF ANATOMY AND PHYSIOLOGY

FEMALE REPRODUCTIVE SYSTEM

The female reproductive system produces female sex hormones that maintain the reproductive cycle.
During menopause, the female reproductive system gradually stops making the female hormones
necessary for the reproductive cycle to work. It is also responsible for nourishing and developing the fetus
and giving birth to the infant.
 REVIEW OF ANATOMY AND PHYSIOLOGY
VAGINA
The vagina is a canal that joins the cervix (the lower part of uterus) to the outside of the
body. It is also known as the birth canal.
 
Uterus
The uterus is a hollow, pear-shaped organ that is the home to a developing fetus. The
uterus is divided into two parts: the cervix, which is the lower part that opens into the vagina,
and the main body of the uterus, called the corpus. The corpus can easily expand to hold a
developing baby. A canal through the cervix allows sperm to enter and menstrual blood to
exit.
 
Ovaries
The ovaries are small, oval-shaped glands that are located on either side of the uterus.
The ovaries produce eggs and hormones.
 
Fallopian tubes
These are narrow tubes that are attached to the upper part of the uterus and serve as
pathways for the ova (egg cells) to travel from the ovaries to the uterus. Fertilization of an
egg by sperm normally occurs in the fallopian tubes. The fertilized egg then moves to the
uterus, where it implants to the uterine lining.
PATHOPHYSIOLOGY
 LABORATORY FINDINGS
DATE   REFERENCE RANGE RESULT
11/04/2022 HEMOGLOBIN 130-180 123
RBC 4.5-6.2 4.05
HEMATOCRIT 40%-50% 38.1
MCV 85+ - 4 94.2
MCH 28+ - 2 30.3
MCHC 300+ -20 322
RDW 11.6-14.6 13.4
PLATELET COUNT 170-400 185
WBC 4 TO 10 12.1
NEUTROPHILS 50-70% 80
LYMPHOCYTES 25-35% 16
MONOCYTES 3-6% 3
EOSINOPHILS 2-4% 1
BASOPHILS 0-1%  

DATE TIME RESULT INTERPRETATION

11/09/2022 1:16 PM SARS-CoV-2 NEGATIVE FOR SARS-CoV-2
ANTIGEN NOT
DETECTED

DATE RESULT
11/03/2022 NEGATIVE

DATE TIME RESULT INTERPRETATION

11/03/2022 9:05 PM SARS-CoV-2 RNA NEGATIVE FOR SARS-CoV-2
NOT DETECTED

DATE RESULT
11/03/2022 Abo Blood Group “ÄB”
RH TYPE: POSITIVE

Assessment
Subjective:
 
“Masakit yung tinahi sakin.
Mababa kasi ang pain
tolerance ko so masasabi ko
na siguro 9 out of 10 para
sakin yung pain.”as
verbalized by the patient.
 
32-year old postpartum
patient who had a Cesarean
Section operation.
 
Medical History:
~Diagnosed with GDM during
her pregnancy and also have
PCOS.
 
Family History:
~Associated with a family
history of asthma and
hypertension.
 
Review of Systems (ROS):
~General:
weight gain and still have a
big tummy or called the C-
section pouch
 
Current Medications,
Allergies:
~Co-amoxiclav PO 620 mg q n
Mefenamic Acid 500 mg PO
OD
Ascorbic Acid 500 mg PO OD
Hemarate FA PO OD
Objective:
Temp: 36.3°C
BP: 120/70 mmHg
PR: 75bpm
RR: 20bpm
Nursing Diagnosis
 
Pain related to disruption of skin,
tissue, and muscle integrity
secondary to Cesarean section
as evidenced by the patient’s
statement of her pain level of 9
out of 10.
NURSING CARE PLAN
Inference
Cesarean section (CS) is the
commonest obstetric procedure in
Ethiopia and worldwide. Pain is the
leading anticipated problem in the
postoperative period.
Pain is a sensory and emotional
experience that is influenced by
physiologic, sensory, affective,
cognitive, sociocultural, and behavioral
factors. Moderate to severe pain after
CS can cause morbidities, patient
discomfort, dissatisfaction, poor wound
healing, delayed recovery, prolonged
hospital stay, poor quality of life, and
chronic pain; all of which have cost
implications. If postoperative pain is
poorly treated particularly in mothers
who underwent CS, it will interfere with
ambulation, breastfeeding, and other
maternal care of the newborn.
 
 
Reference:
(https://www.dovepress.com/
prevalence-and-factors-associated-
with-postoperative-pain-after-cesare-
peer-reviewed-fulltext-article-OAS)
Planning Nursing Interventions Rationale Evaluation
Short-Term Goal: Independent Independent Short-Term Goal:
       
Patient will verbalize reduced intensity of 1. Establish rapport. 1. To gain the trust of the patient. After 8-10 hours of implementing nursing
pain from 9/10 to 5/10 after 8-10 hours of     intervention, the patient verbalized pain level
nursing intervention.   2. To have a comparison during the intervals decreasing from 9/10 to 5/10 with the help
  2. Assess the nature of the pain, including of the nursing intervention and to determine also of the drugs given.
  the location, characteristics, duration, unusual ties.  
Long-Term Goal: frequency, and precipitation factors; use a    
  number scale to rate severity.   Long-Term Goal:
The patient will have no further      
complaints of pain after a week of nursing 3. Perform bedside care.   After a week of implementing the nursing
interventions.     intervention, the patient verbalized to be
  3. To enhance patient’s self-esteem and to healing smoothly and the drugs given are
  provide comfort. prescribed only for a week.
     
4. Keep the area clean, carefully dress the   Therefore, our goals are met.
patient’s wound and keep it free from 4. This will assist the patient’s body to
infections. naturally process repairing.
5. Encourage the patient to perform good  
skin and hygiene.  
  5. Maintaining good body hygiene provides
  a barrier to infection.
Dependent  
   
~Give medication such as Cefuroxime or Dependent
Bactiv for a week.
  ~These drugs are just some of the
  antibiotics that will help the patient from
  having infections due to her operated
  abdomen.
Collaborative Collaborative
Provide optimum nutrition such as increased To provide a positive nitrogen balance to aid
protein intake. in patient’s healing process.
 DRUG STUDY
DRUG ORDER MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES

Generic Name: Diclofenac inhibits cyclooxygenase- Diclofenac is indicated for Diclofenac sodium is contraindicated in -Difficulty having a bowel CNS: headache, dizziness, -Be aware that patient may be at
Diclofenac 1 and -2, the enzymes responsible use in the treatment of pain patients with known hypersensitivity to movement (stool) somnolence, insomnia, fatigue, increased risk for CV events, GI bleed,
  for production of prostaglandin (PG) and inflammation from diclofenac and should not be given to patients -dizziness tiredness, tinnitus, ophthalmic renal insufficiency; monitor accordingly.
Classification: G2 which is the precursor to other varying sources including who have experienced asthma, urticaria, or -pain at the injection site effects -Administer drug with food or after meals if
nonsteroidal anti- PGs.Label,17 These molecules inflammatory conditions other allergic-type reactions after taking Dermatologic: rash, pruritus, GI upset occurs.
inflammatory drug (NSAID) have broad activity in pain and such as osteoarthritis, aspirin or other NSAIDs. sweating, dry mucous membranes, -Arrange for periodic ophthalmologic
  inflammation and the inhibition of rheumatoid arthritis, and stomatitis examination during long-term therapy.
Pregnancy Category B their production is the common ankylosing spondylitis, as GI: nausea, dyspepsia, GI pain, *WARNING: Institute emergency
  mechanism linking each effect of well as injury-related diarrhea, vomiting, constipation, procedures if overdose occurs (gastric
Dosage: diclofenac. inflammation due to surgery flatulence lavage, induction of emesis, supportive
75 mg and physical trauma. It is GU: dysuria, renal impairment therapy).
  often used in combination Hematologic: bleeding, platelet *Provide the patient some teaching points
Route: with misoprostol as a inhibition with higher doses including:
IV gastro-protective agent in Other: peripheral edema, -Take only the prescribed dosage.
  patients with high risk of anaphylactoid reactions to fatal -You may experience these side effects:
Frequency: developing NSAID-induced anaphylactic shock Dizziness, drowsiness (avoid driving or
q 12 hours x 2 doses ulcers. using dangerous machinery while using
this drug).
-Report sore throat, fever, rash, itching,
weight gain, swelling in ankles or fingers,
changes in vision; black, tarry stools.
-Remind the patient that Diclofenac has
been confirmed as a non-threshold
multitargeted drug that causes alterations
in different organs of the body, including
the lung, stomach, kidney, liver, and heart.
-This medicine may raise your risk of
having a heart attack or stroke. This is
more likely in people who already have
heart disease. People who use this
medicine for a long time might also have a
higher risk. This medicine may cause
bleeding in your stomach or intestines.
-This medicine can cause the kidney to
lose the capacity to make these protective
hormones and over time, can result in
progressive kidney damage. This damage
may take years in some people but in
others can occur after a single dose.
 DRUG STUDY

DRUG ORDER MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES

Generic Name: Cefuroxime is a bactericidal agent that For the treatment of many Cefuroxime is contraindicated in patients -vaginal itching -watery or bloody stools, Assess patient for signs and symptoms of
Cefuroxime acts by inhibition of bacterial cell wall different types of bacterial with cephalosporin hypersensitivity or -diarrhea stomach cramps, or fever infection prior to and throughout therapy.
  synthesis. infections such as cephamycin hypersensitivity. Cefuroxime -pain, redness, during treatment or for up to Before initiating therapy, obtain a history to
Classification: antibiotic Cefuroxime has activity in the bronchitis, sinusitis, should be used cautiously in patients with swelling, or bleeding two or more months after determine previous use of and reactions to
Cephalosporin (second presence of some beta-lactamases, tonsillitis, ear infections, skin hypersensitivity to penicillin. The structural near the place where stopping treatment penicillins or cephalosporins. Persons with a
generation) both penicillinases and infections, gonorrhea, and similarity between cefuroxime and penicillin cefuroxime was -seizures negative history of penicillin sensitivity may still
  cephalosporinases, of Gram-negative urinary tract infections. means that cross-reactivity can occur. injected -rash have an allergic response.
Pregnancy Category B and Gram-positive bacteria. -hives Observe patient for signs and symptoms of
  -swelling of the face, throat, anaphylaxis (rash, pruritus, laryngeal edema,
Dosage: tongue, lips, and eyes wheezing). Discontinue the drug and notify
750 mg -difficulty swallowing or physician or other health care professional
  breathing immediately if these symptoms occur. Keep
Route: -hoarseness thromepinephrine, an antihistamine, and
IV -decreased urination resuscitation equipment close by in the event
  -swelling in legs and feet of an anaphylactic reaction.
Frequency: peeling, blistering, or Instruct patient to report signs of
q 8 hours shedding skin hypersensitivity.
a return of fever, sore throat,
chills, or other signs of
infection
-hearing loss, if you are being
treated for meningitis
 DRUG STUDY

DRUG ORDER MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES

Generic Name: Diphenhydramine acts as an Diphenhydramine is a -Documented hypersensitivity to -dry mouth, nose, and -Anaphylaxis/ -Administer with food if GI upset occurs.
Diphenhydramine inverse agonist at the H1 first-generation histamine diphenhydramine throat anaphylactoid reaction -Administer syrup form if patient is unable to take
  receptor, thereby reversing H1 receptor antagonist -Premature infants and neonates -drowsiness tablets.
Classification: the effects of histamine on (H1 antihistamine) that is -Breastfeeding mothers -dizziness -Monitor patient response,and arrange for adjustment
Antihistamines capillaries, reducing allergic widely available as a non- -Pregnancy Category B - used -nausea -QT prolongation of dosage to lowest possible effective dose.
  reaction symptoms. The H1 prescription, over-the- only if clearly needed -vomiting *Provide teaching points to the patient:
Pregnancy Category B receptor is similar to counter (OTC) -Diphenhydramine has additive -loss of appetite - Take as prescribed; avoid excessive dosage.
-Anemia, hemolytic
  muscarinic receptors. medication. As an OTC effects with alcohol and other -constipation -Take with food if GI upset occurs.
Dosage: medication, CNS depressants (hypnotics, -increased c-hest - -Avoid alcohol; serious sedation could occur.
50 mg diphenhydramine is sedatives, tranquilizers) congestion -Thrombocytopenia -These side effects may occur: Dizziness, sedation,
  typically formulated as -Monoamine oxidase A inhibitors headache drowsiness (use caution driving or performing tasks
Route: tablets and creams prolong and intensify the muscle weakness requiring alertness); epigastric distress, diarrhea or
IV indicated for use in anticholinergic effects of excitement (especially in -Agranulocytosis constipation (take drug with meals); dry mouth (use
  treating sneezing, runny antihistamines children) frequent mouth care, suck sugarless lozenges);
Frequency: nose, itchy/watery eyes, nervousness thickening of bronchial secretions, dryness of nasal
q 8 hours PRN itching of nose or throat, -Leukopenia mucosa (use a humidifier).
insomnia, pruritis, -Report difficulty breathing, hallucinations, tremors,
urticaria, insect -Pancytopenia loss of coordination, unusual bleeding or bruising,
bites/stings, allergic visual disturbances, irregular heartbeat.
rashes, and nausea
-Arrhythmias

-Seizures

-Toxic psychosis

-Labyrinthitis, acute

-Heatstroke

 
 DRUG STUDY

DRUG ORDER MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES

Generic Name: Diphenhydramine acts as an Diphenhydramine is a -Documented hypersensitivity to -dry mouth, nose, and -Anaphylaxis/ -Administer with food if GI upset occurs.
Diphenhydramine inverse agonist at the H1 first-generation histamine diphenhydramine throat anaphylactoid reaction -Administer syrup form if patient is unable to take
  receptor, thereby reversing H1 receptor antagonist -Premature infants and neonates -drowsiness tablets.
Classification: the effects of histamine on (H1 antihistamine) that is -Breastfeeding mothers -dizziness -Monitor patient response, and arrange for adjustment
Antihistamines capillaries, reducing allergic widely available as a non- -Pregnancy Category B - used -nausea -QT prolongation of dosage to lowest possible effective dose.
  reaction symptoms. The H1 prescription, over-the- only if clearly needed -vomiting *Provide teaching points to the patient:
Pregnancy Category B receptor is similar to counter (OTC) -Diphenhydramine has additive -loss of appetite - Take as prescribed; avoid excessive dosage.
-Anemia, hemolytic
  muscarinic receptors. medication. As an OTC effects with alcohol and other -constipation -Take with food if GI upset occurs.
Dosage: medication, CNS depressants (hypnotics, -increased c-hest - -Avoid alcohol; serious sedation could occur.
50 mg diphenhydramine is sedatives, tranquilizers) congestion -Thrombocytopenia -These side effects may occur: Dizziness, sedation,
  typically formulated as -Monoamine oxidase A inhibitors headache drowsiness (use caution driving or performing tasks
Route: tablets and creams prolong and intensify the muscle weakness requiring alertness); epigastric distress, diarrhea or
IV indicated for use in anticholinergic effects of excitement (especially in -Agranulocytosis constipation (take drug with meals); dry mouth (use
  treating sneezing, runny antihistamines children) frequent mouth care, suck sugarless lozenges);
Frequency: nose, itchy/watery eyes, nervousness thickening of bronchial secretions, dryness of nasal
q 8 hours PRN itching of nose or throat, -Leukopenia mucosa (use a humidifier).
insomnia, pruritis, -Report difficulty breathing, hallucinations, tremors,
urticaria, insect -Pancytopenia loss of coordination, unusual bleeding or bruising,
bites/stings, allergic visual disturbances, irregular heartbeat.
rashes, and nausea
-Arrhythmias

-Seizures

-Toxic psychosis

-Labyrinthitis, acute

-Heatstroke

 
 DRUG STUDY

DRUG ORDER MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES
Generic Name: Mefenamic acid binds the Mefenamic acid is used to Mefenamic acid is contraindicated in -diarrhea -blurred vision -Assess patients who develop severe diarrhea and
Mefenamic Acid prostaglandin synthetase relieve mild to moderate patients with salicylate hypersensitivity -constipation -unexplained weight vomiting for dehydration and electrolyte imbalance.
  receptors COX-1 and COX- pain, including menstrual or NSAID hypersensitivity who have -gas or bloating gain -Lab tests: With long-term therapy (not
Classification: 2, inhibiting the action of pain (pain that happens experienced asthma, urticaria, or other -headache -shortness of breath or recommended) obtain periodic complete blood
NSAIDs (non-steroidal prostaglandin synthetase. before or during a allergic reactions after taking aspirin or -dizziness difficulty breathing counts, Hct and Hgb, and kidney function tests.
anti-inflammatory drug) As these receptors have a menstrual period). other NSAIDs. Severe, rarely fatal, -nervousness -swelling of feet, *Advise the relative of the patient also to:
central nervous system role as a major mediator of Mefenamic acid is in a anaphylactoid reactions to mefenamic -ringing in the ears ankles, or lower legs -Discontinue drug promptly if diarrhea, dark stools,
agent; analgesic; inflammation and/or a role class of medications acid have been reported in such -fever hematemesis, ecchymoses, epistaxis, or rash occur
antipyretic for prostanoid signaling in called NSAIDs. It works patients. -blisters and do not use again. Contact physician.
  activity-dependent plasticity, by stopping the body's -rash -Notify physician if persistent GI discomfort, sore
Pregnancy Category C the symptoms of pain are production of a substance -itching throat, fever, or malaise occur.
  temporarily reduced. that causes pain, fever, -hives -Do not drive or engage in potentially hazardous
Dosage: and inflammation. -swelling of the eyes, activities until response to drug is known. It may
500 mg face, lips, tongue, cause dizziness and drowsiness.
  throat, hands, or arms Monitor blood glucose for loss of glycemic control if
Route: -difficulty breathing or diabetic.
PO swallowing Do not breast feed while taking this drug without
  -pale skin consulting physician.
Frequency: -fast heartbeat
TID pc x 6 days -excessive tiredness
  -unusual bleeding or
  bruising
  -lack of energy
-nausea
-loss of appetite
-pain in the upper right
part of the stomach
-flu-like symptoms
-yellowing of the skin or
eyes
-cloudy, discolored, or
bloody urine
-back pain
-difficult or painful
urination
 DRUG STUDY

DRUG ORDER MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES
ACTION
Generic Name: Hemarate FA ) is an Prevention and treatment of Hypersensitivity, conditions associated -nausea, -diarrhea, • May cause seizures, hypotension,
Iron + Multivitamins aqueous complex of poly- iron-deficiency anemia and with iron overload (e.g. hemochromatosis, -vomiting, -bloating and -nausea, constipation, epigastric pain, diarrhea, skin
  nuclear Hemarate FA folate deficiency. Lowering hemosiderosis, thalassemia). upper abdomninal -vomiting, staining, anaphylaxis
Brand Name: (Iron (Ferrous Sulfate)) of plasma homocysteine. discomfort, -headache • Assess nutritional status, bowel function
Hemarate FA (III)-hydroxide in sucrose. -diarrhea or constipation -dizziness, • Monitor hemoglobin, hematocrit, iron levels
  Following intravenous -hypotension, • May cause elevated liver enzymes
Classification: administration, Hemarate -pruritus, • Take on an empty stomach to increase
Vitamins & Minerals (Pre FA (Iron (Ferrous Sulfate)) -pain in extremity, absorption/vitamin c helps with
& Post Natal) / is dissociated into -arthralgia, Absorption.
Antianemics Hemarate FA (Iron -back pain,
  (Ferrous Sulfate)) and -muscle cramp, -injection site
Pregnancy Category B sucrose and the reactions,
  Hemarate FA (Iron -chest pain, and peripheral
Dosage: (Ferrous Sulfate)) is edema
  transported as a complex
  with transferrin to target
Route: cells including erythroid
PO precursor cells. The
  Hemarate FA (Iron
Frequency: (Ferrous Sulfate)) in the
OD x 1 month precursor cells is
incorporated into
hemoglobin as the cells
mature into red blood
cells.
 DRUG STUDY

DRUG ORDER MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES

Generic Name: Ascorbic acid functions as Vitamin C is indicated to Vitamin C supplementation is Diarrhea, nausea, vomiting, painful urination, pink/bloody urine *Advise the patient on how to take this medicine
Ascorbic Acid a cofactor, enzyme prevent and treat scurvy. contraindicated in blood disorders like abdominal cramps/pain, or responsively:
  complement, co-substrate, Scurvy develops 1 to 3 thalassemia, G6PD deficiency, sickle cell heartburn Take ascorbic acid exactly as directed. Do not
Classification: and a powerful anti- months after initiating a disease, and hemochromatosis. Avoid take more or less of it or take it more often than
Vitamins, Water- oxidant in various vitamin C deficient diet. taking supplements immediately before or recommended by your doctor.
Soluble reactions and metabolic Individuals may complain following angioplasty. Diabetic patients  
  processes. It also of lethargy, fatigue, should take vitamin C supplements with It may take up to 4 weeks for symptoms of scurvy
Dosage: stabilizes vitamin E and malaise, emotional lability, care as it raises blood sugar levels. to improve.
500 mg folic acid and enhances arthralgias, weight loss,  
  iron absorption. anorexia, and diarrhea. Ascorbic acid supplements are available alone
Route: and in combination with other vitamins.
PO  
  Significant amounts of vitamin C can increase the
Frequency: risk of kidney stones and elevate uric acid and
OD x 2 weeks oxalate because it acidifies the urine.
 
Vitamin C (in grams) can give false negative stool
guaiac results and is rarely associated with fatal
cardiac arrhythmias in patients with iron overload.

DRUG ORDER MECHANISM OF
ACTION
Generic Name: It is bactericidal for both
Co-Amoxiclav gram-positive and
  negative bacteria.
Brand Name: Clavulanate is a β-lactam
Bactiv antibiotic and interacts
  with β-lactamase, this
Classification: interaction may lead to
Penicillins enzyme induction,
  inactivation of the enzyme
Dosage: and hydrolysis of the β-
625 mg lactam ring is used
  clinically only in
Route: combination with
PO amoxicillin.
Frequency:
q 12 hours x 7 days
DRUG STUDY
INDICATION CONTRAINDICATION SIDE EFFECT ADVERSE EFFECT NURSING RESPONSIBILITIES
It's used in adults and Hypersensitivity to penicillins, Diarrhea, pseudomem Hypersensitivity *Advise the patient
children to treat middle cephalosporins or other β-lactams. branous colitis, reactions, GI upset,  
ear and sinus infections. History of jaundice/hepatic impairment indigestion, vomiting, c mucocutaneous This medicine may be taken with or without food: Best
throat or lung respiratory due to co-amoxiclav. andidiasis and phlebitis at candidiasis. Rarely taken at the start of meals for better absorption and to
tract infections. urinary the site of injection hepatitis, cholestatic reduce GI discomfort.
tract infections. jaundice, interstitial  
nephritis, toxic Treatment should not be extended beyond 14 days
epidermal necrolysis, without review.
blood dyscrasias,  
CNS effects, Hepatotoxicity. Amoxicillin-clavulanate has been
antibiotic-associated implicated in hundreds of cases of clinically apparent
colitis acute liver injury and this combination is currently the most
common cause of drug induced liver disease.
 
 RESUME AND VAX CERT OF STUDENTS

Name: Urich Matthew A. Claudio

Age: 20
Birthdate: March 18, 2002
Birthplace: Rosario Batangas
Present address: Mahogany Subd. Brgy. Kayumanggi
Mobile no.: 09560673879
Email address: urichclaudio@gmail.com
Course and year: 2nd Year Bachelor of Science in Nursing

VACCINATION CERTIFICATE
Dosage Date Vaccine
1 dose
st
10/11/2021 Pfizer
2nd dose 11/03/2021 Pfizer
 RESUME AND VAX CERT OF STUDENTS

Name: April Lou Bernadette A. Latade

Age: 20
Birthdate: April 25, 2002
Birthplace: Lipa City
Present address: Block 13 Lot 2 Joel St. Sampaguita West Subd. Brgy.
Sampaguita Lipa City
Mobile no.: 09298668061
Email address: aprilaguilera03@gmail.com
Course and year: 2nd Year Bachelor of Science in Nursing
VACCINATION CERTIFICATE

Dosage Date Vaccine

1 dose
st
10/11/2021 Pfizer
2nd dose 11/03/2022 Pfizer
 RESUME AND VAX CERT OF STUDENTS

Name: Mecaela Lorie F. Magpantay

Age: 20
Birthdate: November 18, 2002
Birthplace: Pansol, Padre Garcia Batangas
Present address: Payapa Padre Garcia Batangas
Mobile no.: 09934065030
Email address: magpantaymecaela636@gmail.com
Course and year: 2nd Year Bachelor of Science in Nursing

VACCINATION CERTIFICATE
Dosage Date Vaccine
1 dose
st
10/27/21 MODERNA
2nd dose 11/15/21 MODERNA
 RESUME AND VAX CERT OF STUDENTS

Name: Krisha Denise A. Morcilla

Age: 19
Birthdate: December 11, 2002
Birthplace: Lipa City
Present address: San Andres Malvar, Batangas
Mobile no.: 09673678454
Email address: krishamorcilla@gmail.com
Course and year: 2nd Year Bachelor of Science in Nursing

VACCINATION CERTIFICATE
Dosage Date Vaccine
1 dose
st
12/30/2021 Sinovac
2nd dose 01/19/2022 Sinovac
 RESUME AND VAX CERT OF STUDENTS

Name: Rose Angela G. Rivera

Age: 20
Birthdate: December 4, 2001
Birthplace: Balicutan Hospital Magalang Pampanga
Present address: Lot 2 Block Genoa Street Bon Giorno Homes Brgy. Munting
Pulo, Lipa City, Bats.
Mobile no.: 09366250651
Email address: roseangelarivera10@gmai.com
Course and year: 2nd Year Bachelor of Science in Nursing
VACCINATION CERTIFICATE

Dosage Date Vaccine

1 dose
st
10/31/2021 Sinovac
2nd dose 11/10/2022 Sinovac
 RESUME AND VAX CERT OF STUDENTS

Name: Chantemayne M. Villanueva

Age: 20
Birthdate: July 4, 2002
Birthplace: Lipa City
Present address: Blk9 Lot5 Monte Flora Homes Sabang, Lipa City
Mobile no.: 09452885478
Email address: chantemayne.villanueva@gmail.com
Course and year: 2nd Year Bachelor of Science in Nursing

VACCINATION CERTIFICATE
Dosage Date Vaccine
1 dose
st
08/19/2021 Pfizer
2nd dose 09/09/2021 Pfizer
THANK YOU FOR
LISTENING
TO OUR CASE
PRESENTATION!